Cessatech A/S announced the appointment of Rachel Curtis Gravesen as an observer to the board of directors. The intention is that she will be proposed as a member of the board at the company's Annual General Meeting, which is scheduled to be held in March 2022. This appointment follows Ulla Buhl's decision to resign as a member of the board of directors to focus on other activities. Rachel Curtis Gravesen has over 25 years' experience in leadership, business and communication, and has held multiple roles in investor relations and communications. She currently runs her own strategic investor relations and communications consultancy company working with biotechnology companies, and earlier held roles at
Genmab and Novo Nordisk as well as working as a journalist at CNBC Nordic and the BBC.